CORNELL PETERS: Open Payments
NPI 1861487225 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 52 payments from 22 companies in 2025. Trend: 2023 $1,004 · 2024 $1,491 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $361 |
| Sumitomo Pharma America, Inc. | 9 | $266 |
| ABBVIE INC. | 7 | $265 |
| Novo Nordisk Inc | 5 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Boston Scientific Corporation | 1 | $41 |
| Ardelyx, Inc. | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| PFIZER INC. | 1 | $27 |
Products named: BREZTRI, GEMTESA, QULIPTA, FANAPT, Ozempic, JARDIANCE, LINZESS, WaveWriter Alpha Prime 16.
Industry payments across GA — which companies pay providers there.
